These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8836109

  • 21. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
    Gasinska A, Fowler JF, Lind BK, Urbanski K.
    Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
    [Abstract] [Full Text] [Related]

  • 22. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration.
    Agrawal S, Zhang X, Lu Z, Zhao H, Tamburin JM, Yan J, Cai H, Diasio RB, Habus I, Jiang Z.
    Biochem Pharmacol; 1995 Aug 08; 50(4):571-6. PubMed ID: 7646565
    [Abstract] [Full Text] [Related]

  • 23. Dosimetry and optimization of in vivo targeting with radiolabeled antisense oligodeoxynucleotides: oligonucleotide radiotherapy.
    Kairemo KJ, Jekunen AP, Tenhunen M.
    Methods Enzymol; 2000 Aug 08; 314():506-24. PubMed ID: 10565036
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In vivo stability, disposition and metabolism of a "hybrid" oligonucleotide phosphorothioate in rats.
    Zhang R, Lu Z, Zhao H, Zhang X, Diasio RB, Habus I, Jiang Z, Iyer RP, Yu D, Agrawal S.
    Biochem Pharmacol; 1995 Aug 08; 50(4):545-56. PubMed ID: 7646561
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
    Barone R, Walrand S, Konijnenberg M, Valkema R, Kvols LK, Krenning EP, Pauwels S, Jamar F.
    Nucl Med Commun; 2008 Mar 08; 29(3):283-90. PubMed ID: 18349800
    [Abstract] [Full Text] [Related]

  • 33. Use of 33P for Sanger DNA sequencing.
    Zagursky RJ, Conway PS, Kashdan MA.
    Biotechniques; 1991 Jul 08; 11(1):36, 38. PubMed ID: 1954015
    [Abstract] [Full Text] [Related]

  • 34. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L.
    Clin Cancer Res; 2005 Jan 01; 11(1):361-9. PubMed ID: 15671567
    [Abstract] [Full Text] [Related]

  • 35. 33P is preferable to 35S for labeling probes used in in situ hybridization.
    McLaughlin SK, Margolskee RF.
    Biotechniques; 1993 Sep 01; 15(3):506-11. PubMed ID: 8217166
    [Abstract] [Full Text] [Related]

  • 36. In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats.
    Zhang R, Lu Z, Zhang X, Zhao H, Diasio RB, Liu T, Jiang Z, Agrawal S.
    Clin Chem; 1995 Jun 01; 41(6 Pt 1):836-43. PubMed ID: 7768001
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Simultaneous measurement of 32P and a 33P double-labelled sample by liquid scintillation counter and its application to phosphorus compounds isolated by paper chromatography].
    Sasaki Y, Arima Y, Kumazawa K.
    Radioisotopes; 1982 Jun 01; 31(6):279-84. PubMed ID: 7178536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.